Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the pharmacokinetics, safety, and tolerability of
fesoterodine following administration to pediatric patients, aged 8-17 years, with overactive
bladder.